{"id":"NCT03882970","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes","officialTitle":"A Randomized, Phase 3, Open-Label Trial Comparing the Effect of LY3298176 Versus Titrated Insulin Degludec on Glycemic Control in Patients With Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-04-01","primaryCompletion":"2020-12-11","completion":"2021-01-04","firstPosted":"2019-03-20","resultsPosted":"2022-01-19","lastUpdate":"2022-01-19"},"enrollment":1444,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"Tirzepatide","otherNames":["LY3298176"]},{"type":"DRUG","name":"Insulin Degludec","otherNames":[]}],"arms":[{"label":"5 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"10 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"15 mg Tirzepatide","type":"EXPERIMENTAL"},{"label":"Insulin Degludec","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the effect of the study drug tirzepatide to insulin degludec on blood sugar levels in participants with type 2 diabetes. The study will last about 67 weeks and may include up to 22 visits.","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin A1c (HbA1c) (10 mg and 15 mg)","timeFrame":"Baseline, Week 52","effectByArm":[{"arm":"10 mg Tirzepatide","deltaMin":-2.2,"sd":0.051},{"arm":"15 mg Tirzepatide","deltaMin":-2.37,"sd":0.05},{"arm":"Insulin Degludec","deltaMin":-1.34,"sd":0.049}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":122,"countries":["United States","Argentina","Austria","Greece","Hungary","Italy","Poland","Puerto Rico","Romania","South Korea","Spain","Taiwan","Ukraine"]},"refs":{"pmids":["40318682","39531161","37668888","37526908","37000390","35468325","35468321","35210595","34370970"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/76cf8Mdt50agkx23op5368"]},"adverseEventsSummary":{"seriousAny":{"events":29,"n":358},"commonTop":["Nausea","Diarrhoea","Decreased appetite","Vomiting","Dyspepsia"]}}